ConductScience.org, home

Paper2136347

Structure and properties of a Cephalosporium acremonium alpha-galactosidase.

Zaprometova OM and 2 others. Glycoconj J, 1990. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Structure and properties of a Cephalosporium acremonium alpha-galactosidase. Papers, record 2136347. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2136347

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Structure and properties of a Cephalosporium acremonium alpha-galactosidase.
PubMed
Journal
Glycoconj J
PubMed
Year
1990
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.1
iCite
Revised in PubMed
2019-10-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zaprometova OMO M
2Ulezlo IVI V
3Lakhtin VMV M

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcremoniumMajor topic
GalactosidasesMajor topic
Amino Acids
Carbohydrates
Chromatography, Gas
Enzyme Stability
Hydrogen-Ion Concentration
Kinetics
Substrate Specificity
Temperature

Source PubMed

Download CSV of topics

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16282754Degradation of intestinal glycoproteins by pathogenic Shigella flexneri.Infect Immun1982https://conductscience.org/library/papers/6282754PubMed
23149074[Isolation and identification of products of accumulation in Fabry disease].Vopr Med Khim1988https://conductscience.org/library/papers/3149074PubMed
36810751Enzyme therapy: problems and solutions.Annu Rev Biochem1982https://conductscience.org/library/papers/6810751PubMed
56304953Action of alpha-galactosidase from Clostridium sporogenes and coffee beans on blood group B antigen of erythrocytes. The effect on the viability of erythrocytes in circulation.Transfusion1983https://conductscience.org/library/papers/6304953PubMed
6216315alpha-Galactosidase (melibiase) from Saccharomyces carlsbergensis: structrual and kinetic properties.Arch Biochem Biophys1978https://conductscience.org/library/papers/216315PubMed
76256279The role of membrane sialyl and galactosyl residues in regulation of the life-time of rabbit erythrocytes.Hoppe Seylers Z Physiol Chem1980https://conductscience.org/library/papers/6256279PubMed
86859520A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation.Anal Biochem1983https://conductscience.org/library/papers/6859520PubMed
95418105Alpha-galactosidase from Mortierella vinacea. Crystallization and properties.J Biol Chem1970https://conductscience.org/library/papers/5418105PubMed
106331399Glycosidases induced in Aspergillus tamarii. Secreted alpha-D-galactosidase and beta-D-mannanase.Biochem J1984https://conductscience.org/library/papers/6331399PubMed
116331398Glycosidases induced in Aspergillus tamarii. Mycelial alpha-D-galactosidases.Biochem J1984https://conductscience.org/library/papers/6331398PubMed
1216661250Legume alpha-Galactosidases Which Have Hemagglutinin Properties.Plant Physiol1980https://conductscience.org/library/papers/16661250PubMed
136320603Biochemistry of the multiple forms of glycosidases in plants.Adv Enzymol Relat Areas Mol Biol1984https://conductscience.org/library/papers/6320603PubMed
1416662262An alpha-Galactosidase with Hemagglutinin Properties from Soybean Seeds.Plant Physiol1982https://conductscience.org/library/papers/16662262PubMed
152831880Purification and analysis of the structure of alpha-galactosidase from Escherichia coli.Biochem Biophys Res Commun1988https://conductscience.org/library/papers/2831880PubMed
176338937Role of membrane integral proteins in the modulation of red cell shape by albumin, dinitrophenol and the glass effect.Biochim Biophys Acta1983https://conductscience.org/library/papers/6338937PubMed
1839940Studies on human liver alpha-galactosidases. I. Purification of alpha-galactosidase A and its enzymatic properties with glycolipid and oligosaccharide substrates.J Biol Chem1979https://conductscience.org/library/papers/39940PubMed
1914112Glycoprotein enzymes secreted by Aspergillus niger: purification and properties of alpha-glaactosidase.J Bacteriol1977https://conductscience.org/library/papers/14112PubMed

Download CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
8390816Conditions of formation, purification, and characterization of an alpha-galactosidase of Trichoderma reesei RUT C-30.Appl Environ Microbiol1993https://conductscience.org/library/papers/8390816

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2136347

GET https://conductscience.org/api/papers/v1/2136347/authors